BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 11766829)

  • 1. Acute ventricular reduction with the acorn cardiac support device: effect on progressive left ventricular dysfunction and dilation in dogs with chronic heart failure.
    Chaudhry PA; Anagnostopouls PV; Mishima T; Suzuki G; Nair H; Morita H; Sharov VG; Alferness C; Sabbah HN
    J Card Surg; 2001; 16(2):118-26. PubMed ID: 11766829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global left ventricular remodeling with the Acorn Cardiac Support Device: hemodynamic and angiographic findings in dogs with heart failure.
    Sabbah HN
    Heart Fail Rev; 2005 Jun; 10(2):109-15. PubMed ID: 16258718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Passive epicardial containment prevents ventricular remodeling in heart failure.
    Chaudhry PA; Mishima T; Sharov VG; Hawkins J; Alferness C; Paone G; Sabbah HN
    Ann Thorac Surg; 2000 Oct; 70(4):1275-80. PubMed ID: 11081885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular histomorphometric findings in dogs with heart failure treated with the Acorn Cardiac Support Device.
    Sharov VG; Todor AV; Sabbah HN
    Heart Fail Rev; 2005 Jun; 10(2):141-7. PubMed ID: 16258721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left atrial reverse remodeling in dogs with moderate and advanced heart failure treated with a passive mechanical containment device: an echocardiographic study.
    Zacà V; Brewer R; Khanal S; Imai M; Jiang A; Wang M; Goldstein S; Sabbah HN
    J Card Fail; 2007 May; 13(4):312-7. PubMed ID: 17517352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained benefits of the CorCap Cardiac Support Device on left ventricular remodeling: three year follow-up results from the Acorn clinical trial.
    Starling RC; Jessup M; Oh JK; Sabbah HN; Acker MA; Mann DL; Kubo SH
    Ann Thorac Surg; 2007 Oct; 84(4):1236-42. PubMed ID: 17888975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of chronic molecular and cellular abnormalities due to heart failure by passive mechanical ventricular containment.
    Sabbah HN; Sharov VG; Gupta RC; Mishra S; Rastogi S; Undrovinas AI; Chaudhry PA; Todor A; Mishima T; Tanhehco EJ; Suzuki G
    Circ Res; 2003 Nov; 93(11):1095-101. PubMed ID: 14563716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cardiac support device and the myosplint: treating heart failure by targeting left ventricular size and shape.
    Sabbah HN
    Ann Thorac Surg; 2003 Jun; 75(6 Suppl):S13-9. PubMed ID: 12820730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-year clinical experience with the Acorn CorCap cardiac support device: results of a limited market release safety study in Italy and Sweden.
    Livi U; Alfieri O; Vitali E; Russo C; Frigerio M; Tursi V; Albanese MC; De Bonis M; Fragasso G; Franco-Cereceda A; Forssell G; Rorke R; Kubo SH
    Ital Heart J; 2005 Jan; 6(1):59-65. PubMed ID: 15773275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure.
    Suzuki G; Morita H; Mishima T; Sharov VG; Todor A; Tanhehco EJ; Rudolph AE; McMahon EG; Goldstein S; Sabbah HN
    Circulation; 2002 Dec; 106(23):2967-72. PubMed ID: 12460880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of long-term therapy with bosentan on the progression of left ventricular dysfunction and remodeling in dogs with heart failure.
    Mishima T; Tanimura M; Suzuki G; Todor A; Sharov VG; Goldstein S; Sabbah HN
    J Am Coll Cardiol; 2000 Jan; 35(1):222-9. PubMed ID: 10636284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of left ventricular wall thickness with alginate hydrogel implants improves left ventricular function and prevents progressive remodeling in dogs with chronic heart failure.
    Sabbah HN; Wang M; Gupta RC; Rastogi S; Ilsar I; Sabbah MS; Kohli S; Helgerson S; Lee RJ
    JACC Heart Fail; 2013 Jun; 1(3):252-8. PubMed ID: 23998003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and feasibility of a cardiac support device.
    Konertz W; Dushe S; Hotz H; Braun JP; Spiess C; Endzweiler C; Stantke K; Sapsford E; Sabbah H; Kleber FX
    J Card Surg; 2001; 16(2):113-7. PubMed ID: 11766828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous mitral valve repair in the initial EVEREST cohort: evidence of reverse left ventricular remodeling.
    Foster E; Kwan D; Feldman T; Weissman NJ; Grayburn PA; Schwartz A; Rogers JH; Kar S; Rinaldi MJ; Fail PS; Hermiller J; Whitlow PL; Herrmann HC; Lim DS; Glower DD;
    Circ Cardiovasc Imaging; 2013 Jul; 6(4):522-30. PubMed ID: 23633132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reverse remodeling and enhanced adrenergic reserve from passive external support in experimental dilated heart failure.
    Saavedra WF; Tunin RS; Paolocci N; Mishima T; Suzuki G; Emala CW; Chaudhry PA; Anagnostopoulos P; Gupta RC; Sabbah HN; Kass DA
    J Am Coll Cardiol; 2002 Jun; 39(12):2069-76. PubMed ID: 12084610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cardiac support device on reverse remodeling: molecular, biochemical, and structural mechanisms.
    Sabbah HN
    J Card Fail; 2004 Dec; 10(6 Suppl):S207-14. PubMed ID: 15803552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective matrix metalloproteinase inhibition attenuates progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure.
    Morita H; Khanal S; Rastogi S; Suzuki G; Imai M; Todor A; Sharov VG; Goldstein S; O'Neill TP; Sabbah HN
    Am J Physiol Heart Circ Physiol; 2006 Jun; 290(6):H2522-7. PubMed ID: 16428338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure.
    St John Sutton MG; Plappert T; Abraham WT; Smith AL; DeLurgio DB; Leon AR; Loh E; Kocovic DZ; Fisher WG; Ellestad M; Messenger J; Kruger K; Hilpisch KE; Hill MR;
    Circulation; 2003 Apr; 107(15):1985-90. PubMed ID: 12668512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left Ventricular Architecture, Long-Term Reverse Remodeling, and Clinical Outcome in Mild Heart Failure With Cardiac Resynchronization: Results From the REVERSE Trial.
    St John Sutton M; Linde C; Gold MR; Abraham WT; Ghio S; Cerkvenik J; Daubert JC;
    JACC Heart Fail; 2017 Mar; 5(3):169-178. PubMed ID: 28254122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infarct size reduction and attenuation of global left ventricular remodeling with the CorCap cardiac support device following acute myocardial infarction in sheep.
    Blom AS; Pilla JJ; Gorman RC; Gorman JH; Mukherjee R; Spinale FG; Acker MA
    Heart Fail Rev; 2005 Jun; 10(2):125-39. PubMed ID: 16258720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.